 |
|
Preclinical study suggests organ-transplant drug may aid in lupus fight
August 16, 2007A compound related to a drug used in humans to prevent organ-transplant rejection attacks a key biochemical process in the faulty immune cells of lupus-prone mice, suggesting a possible new approach to combating the disease, UT Southwestern Medical Center researchers have found.
"We found that an analog of rapamycin is very effective in improving all aspects of the disease in lupus-prone mice," said Dr. Chandra Mohan, professor of internal medicine and senior author of a study appearing in the August issue of the Journal of Clinical Investigation. "Our next step will be to see if the same biochemical pathways exist in humans. If they do, this research and treatment could prove very significant."
Lupus is a chronic autoimmune disease in which the immune system attacks the body's cells and tissues. In a normal immune system, foreign intruders are recognized by special immune cells called B-cells, which produce antibodies. In patients with lupus, however, the antibodies created by the B-cells start to attack the body itself.
Certain genetic strains of mice are prone to developing lupus. In the current study, a research team led by Dr. Mohan discovered that an analog of rapamycin shuts down specific biochemical processes in the B-cells of the mice. Rapamycin has been used in humans to prevent organ transplant rejection and for treating cancer. The analog of rapamycin halted production of antibodies and the development of lupus in all the strains of lupus-prone mice, as well as improved symptoms, despite each animal having a different genetic makeup that led to the disease.
"Though lupus in different mouse models may originate from different genetic triggers, those triggers ultimately funnel through a shared series of biochemical pathways that lead to the disease," Dr. Mohan said. "These shared biochemical pathways represent an attractive target for future therapeutic intervention in lupus patients."
In humans, lupus can cause life-threatening damage to the kidneys, lungs, heart, central nervous system, joints, blood vessels and skin. It can be associated with severe fatigue, joint pain, skin rashes, hair loss and neurological problems. Although treatable symptomatically, there is currently no cure for the disease, which affects up to 1 million people in the U.S.
Other UT Southwestern researchers involved with the study were Dr. Tianfu Wu, assistant instructor of immunology; Xiangmei Qin, research assistant in immunology; Zoran Kurepa, immunology resident; Kirthi Raman Kumar, postdoctoral trainee in internal medicine; Dr. Kui Liu, instructor of internal medicine; Hasna Kanta, research assistant in internal medicine; Dr. Xin J. Zhou, professor of pathology; Dr. Anne Satterthwaite, assistant professor of immunology; and Dr. Laurie Davis, associate professor of immunology.
The research was funded by the National Institutes of Health and the Alliance for Lupus Research.
The University of Texas Southwestern Medical Center at Dallas
Certain genetic strains of mice are prone to developing lupus. In the current study, a research team led by Dr. Mohan discovered that an analog of rapamycin shuts down specific biochemical processes in the B-cells of the mice. Rapamycin has been used in humans to prevent organ transplant rejection and for treating cancer. The analog of rapamycin halted production of antibodies and the development of lupus in all the strains of lupus-prone mice, as well as improved symptoms, despite each animal having a different genetic makeup that led to the disease.
"Though lupus in different mouse models may originate from different genetic triggers, those triggers ultimately funnel through a shared series of biochemical pathways that lead to the disease," Dr. Mohan said. "These shared biochemical pathways represent an attractive target for future therapeutic intervention in lupus patients."
In humans, lupus can cause life-threatening damage to the kidneys, lungs, heart, central nervous system, joints, blood vessels and skin. It can be associated with severe fatigue, joint pain, skin rashes, hair loss and neurological problems. Although treatable symptomatically, there is currently no cure for the disease, which affects up to 1 million people in the U.S.
Other UT Southwestern researchers involved with the study were Dr. Tianfu Wu, assistant instructor of immunology; Xiangmei Qin, research assistant in immunology; Zoran Kurepa, immunology resident; Kirthi Raman Kumar, postdoctoral trainee in internal medicine; Dr. Kui Liu, instructor of internal medicine; Hasna Kanta, research assistant in internal medicine; Dr. Xin J. Zhou, professor of pathology; Dr. Anne Satterthwaite, assistant professor of immunology; and Dr. Laurie Davis, associate professor of immunology.
The research was funded by the National Institutes of Health and the Alliance for Lupus Research.
The University of Texas Southwestern Medical Center at Dallas
Lupus Current Events and Lupus News RSSPotential autoimmunity-inducing cells found in healthy adults
It's not just patients with autoimmune diseases like lupus and rheumatoid arthritis (RA) that have self-attacking immune cells-healthy people have them too, according to a new report in the Journal of Experimental Medicine.
Penn Scientists Show How Body Determines Optimal Amount of Germ-Fighting B Cells
Researchers at the University of Pennsylvania School of Medicine can now explain how the body determines whether there are enough mature B-cells in the blood stream at any one time. These are the cells that produce antibodies against germs to fight infections.
A reversal of thinking: How women with lupus can increase chance for healthy pregnancies
In the not so distant past, women with systemic lupus erythematosus (SLE), an autoimmune disease, were advised not to have children, and if they became pregnant, to have therapeutic abortions to prevent severe flares of their lupus.
Green tea may delay onset of type 1 diabetes
A powerful antioxidant in green tea may prevent or delay the onset of type 1 diabetes, Medical College of Georgia researchers say.
Statins may prevent miscarriages
Hospital for Special Surgery researchers have found that statins may be able to prevent miscarriages in women who are suffering from pregnancy complications caused by antiphospholipid syndrome (APS), according to a study in mice.
Hodgkin lymphoma -- new characteristics discovered
Researchers are still discovering new characteristics of Hodgkin lymphoma, a common form of cancer of the lymphatic system. The malignant cells are derived from white blood cells (B cells), but have lost a considerable part of the B cell-specific gene expression pattern.
Wistar researchers invigorate 'exhausted' immune cells
In battles against chronic infections, the body's key immune cells often become exhausted and ineffective. Researchers at The Wistar Institute have found a way to restore vigor to these killer T cells by blocking a key receptor on their surface, findings that may advance the development of new therapies for diseases such as HIV, hepatitis B and C, and cancer.
Key protein molecule linked to diverse human chronic inflammatory diseases
Liwu Li, associate professor of biological sciences at Virginia Tech, has revealed a common connection between the cellular innate immunity network and human chronic inflammatory diseases, including atherosclerosis, Type 2 Diabetes, and neurodegenerative diseases.
Accumulated bits of a cell's own DNA can trigger autoimmune disease
A security system wired within every cell to detect the presence of rogue viral DNA can sometimes go awry, triggering an autoimmune response to single-stranded bits of the cell's own DNA, according to a report in the August 22nd issue of the journal Cell, a Cell Press publication.
UT Pathologists Believe They Have Pinpointed Achilles Heel of HIV
Human Immunodeficiency Virus (HIV) researchers at The University of Texas Medical School at Houston believe they have uncovered the Achilles heel in the armor of the virus that continues to kill millions.
More Lupus Current Events and Lupus News Articles
 | The Lupus Book: A Guide for Patients and Their Families by Daniel J Wallace Lupus, a disease of the immune system, can be quite deadly, claiming the lives of thousands of patients yearly. Dr. Daniel J. Wallace is one of the world's leading authorities on this disorder, an eminent clinician who has treated over 2000 lupus patients, the largest such practice in America. His The Lupus Book, originally published in 1995, immediately established itself as the most readable... |
 | The Lupus Recovery Diet: A Natural Approach to Autoimmune Disease That Really Works by Jill Harrington This could be the most important book you'll ever read if you, or someone you love, has lupus. Jill Harrington, the author, recovered from lupus over twelve years ago, using a specific diet and lifestyle. And... she's not the only one. You will read the stories of other people who have done the same thing. It isn't widely known how much of an effect the foods you eat can have on lupus and other... |
 | The First Year--Lupus: An Essential Guide for the Newly Diagnosed by Nancy C. Hanger A patient-expert walks those newly diagnosed with lupus through everything they need to learn and do during their first year with the condition Lupus, a serious rheumatological, autoimmune disease found predominantly in women, affects the connective tissues and linings throughout the body. Because of the diversity of its symptoms and severity with which it can manifest, it remains one of the... |
 | New Hope for People with Lupus: Your Friendly, Authoritive Guide to the Latest in Traditional and Complementary Solutions by Theresa Foy Digeronimo, Sara J. Henry Discover Exciting New Ways to Manage LupusNow you can take control of lupus and begin living a healthier, better life—today! This thoughtful, cutting-edge book can help you manage the flare-ups, symptoms, and side effects of lupus and put you back on the path to a more enjoyable, active lifesyle. Inside is compassionate, practical, and immediate guidance for anyone affected by lupus, including:... |
 | Dubois' Lupus Erythematosus Established for forty years as the definitive reference on lupus, Dubois' Lupus Erythematosus is now in its thoroughly revised, updated Seventh Edition. More than ninety distinguished contributing authors--twenty of them new to this edition--provide comprehensive coverage of every aspect of cutaneous and systemic lupus erythematosus, including definitions, pathogenesis, autoantibodies, clinical... |
 | Julie's Story, My Life With Lupus by Julie Miller Julie's Story, 'My Life With Lupus', sums up the challenges and struggles of a young woman's life in dealing with the very unpredictable disease, Lupus. Julie was a young and energetic twenty- four- year- old woman with her whole life ahead of her. Planning the wedding of her dreams to her college sweetheart and finishing her Master's degree in Social Work, life couldn't get any better!Although... |
 | Lupus: Alternative Therapies That Work by Sharon Moore A comprehensive guide to noninvasive, nontoxic therapies for lupus--written by a lupus survivor. * The only book to focus on alternative therapies for lupus. * Includes therapeutic approaches drawn from the fields of naturopathic medicine, nutritional medicine, environmental medicine, traditional Chinese medicine, nontoxic dentistry, energy medicine, and psychological healing. * Lupus affects... |
 | Healing Lupus: Steps in a Personal Journey by Waverly Evans Healing Lupus gives an enlightening and instructive account of the author's personal journey with lupus over a seven-year period, from diagnosis to healing. Ms. Evans shares her personal insights and gifts that led to her healing as well as the tools that helped her get there. She has been free from lupus since... |
 | Coping With Lupus: A Practical Guide to Alleviating the Challenges of Systemic Lupus Erythematosus by Robert H. Phillips A top-seller in Avery's Coping with a Chronic Illness series (more than 78,000 sold) is now thoroughly revised and updated.More than sixteen thousand Americans develop lupus each year, according to the Lupus Foundation of America. Once considered a fatal disease of the autoimmune system, current methods of therapy have made deaths from lupus much more uncommon. Many patients now live longer lives... |
 | Lupus Erythematosus (The Clinical Practice of Chinese Medicine) by Chen Da-can, Xuan Guo-wei Lupus erythematosus is a chronic autoimmune disease that seriously influences the health of the body. The prevalence of lupus erythematosus is rising, but the etiology still remains unclear. Currently, glucocorticoids and immunosuppressants are mainly used to ease the symptoms and reduce complications. But long-term application of these medicines causes many side-effects, such as infection,... |
| © 2009 BrightSurf.com |